Journey Net Debt from 2010 to 2024

DERM Stock

USD 5.37 0.17 3.27%

Journey Medical Net Debt yearly trend continues to be very stable with very little volatility. Net Debt is likely to drop to about -10.2 M. Net Debt is the total debt of Journey Medical Corp minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. View All Fundamentals

Net Debt

First Reported

2014-12-31

Previous Quarter

-1.1 M

Current Value

-2.6 M

Quarterly Volatility

104.7 M

Yuan Drop

Covid

Check Journey Medical financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Journey Medical's main balance sheet or income statement drivers, such as Depreciation And Amortization of 4 M, Interest Expense of 1.6 M or Selling General Administrative of 53.8 M, as well as many indicators such as Price To Sales Ratio of 1.26, Dividend Yield of 0.0 or PTB Ratio of 3.5. Journey financial statements analysis is a perfect complement when working with Journey Medical Valuation or Volatility modules.

Check out the analysis of Journey Medical Correlation against competitors.

Latest Journey Medical's Net Debt Growth Pattern

Below is the plot of the Net Debt of Journey Medical Corp over the last few years. It is the total debt of a company minus its cash and cash equivalents. It represents the actual debt burden on the company after accounting for the liquid assets it holds. Journey Medical's Net Debt historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Journey Medical's overall financial position and show how it may be relating to other accounts over time.

Net Debt

10 Years Trend

Slightly volatile

Compare to Others All Fundamentals

Net Debt

Timeline

Journey Net Debt Regression Statistics

	Arithmetic Mean	(20,221,363)
	Coefficient Of Variation	(344.32)
	Mean Deviation	40,339,346
	Median	(41,793,000)
	Standard Deviation	69,625,736
	Sample Variance	4847.7T
	Range	316.1M
	R-Value	0.33
	Mean Square Error	4662.3T
	R-Squared	0.11
	Significance	0.23
	Slope	5,091,510
	Total Sum of Squares	67868.4T

Journey Net Debt History

	2024	-10.2 M
	2023	-9.7 M
	2022	-9 M
	2021	-48.2 M
	2020	-2.8 M
	2019	502 K
	2018	208.8 M

Other Fundumenentals of Journey Medical Corp

Net Debt To E B I T D A

Journey Medical Net Debt component correlations

	Total Assets	Total Stockholder Equity	Current Deferred Revenue	Net Debt	Retained Earnings	Accounts Payable	Net Receivables	Good Will	Short Term Investments	Total Liab	Total Current Assets	Short Term Debt	Intangible Assets	Common Stock	Net Tangible Assets	Long Term Debt	Net Invested Capital	Capital Stock	Net Working Capital	Property Plant Equipment	Short Long Term Debt
Total Assets		0.48	-0.14	0.2	-0.83	0.05	-0.59	0.31	0.12	0.78	0.98	0.24	-0.62	0.87	-0.06	-0.4	-0.47	-0.43	-0.38	-0.46	-0.35
Total Stockholder Equity	0.48		-0.3	-0.6	-0.03	-0.33	-0.33	0.35	-0.54	-0.17	0.36	-0.01	-0.67	0.66	-0.03	-0.5	-0.57	-0.53	-0.43	-0.57	-0.46
Current Deferred Revenue	-0.14	-0.3		0.31	-0.06	-0.28	0.1	0.59	0.02	0.02	-0.1	-0.32	-0.28	-0.05	0.58	-0.16	-0.18	-0.34	0.1	-0.39	-0.61
Net Debt	0.2	-0.6	0.31		-0.68	0.21	-0.17	-0.06	0.44	0.64	0.27	-0.17	0.04	0.15	-0.12	-0.01	0.0	0.01	-0.06	0.1	0.08
Retained Earnings	-0.83	-0.03	-0.06	-0.68		-0.18	0.49	-0.15	-0.32	-0.91	-0.87	-0.1	0.44	-0.73	0.09	0.27	0.31	0.27	0.27	0.29	0.2
Accounts Payable	0.05	-0.33	-0.28	0.21	-0.18		0.41	-0.18	0.52	0.3	0.13	0.69	0.61	-0.22	0.13	0.84	0.77	0.75	0.53	0.45	0.65
Net Receivables	-0.59	-0.33	0.1	-0.17	0.49	0.41		-0.12	0.42	-0.43	-0.47	0.23	0.62	-0.67	0.17	0.56	0.59	0.48	0.45	0.48	0.36
Good Will	0.31	0.35	0.59	-0.06	-0.15	-0.18	-0.12		-0.23	0.03	0.25	-0.22	-0.55	0.42	0.31	-0.33	-0.46	-0.54	-0.33	-0.49	-0.58
Short Term Investments	0.12	-0.54	0.02	0.44	-0.32	0.52	0.42	-0.23		0.51	0.29	0.56	0.43	-0.27	0.07	0.42	0.47	0.46	0.37	0.46	0.39
Total Liab	0.78	-0.17	0.02	0.64	-0.91	0.3	-0.43	0.03	0.51		0.84	0.29	-0.2	0.51	-0.06	-0.09	-0.11	-0.1	-0.11	-0.11	-0.06
Total Current Assets	0.98	0.36	-0.1	0.27	-0.87	0.13	-0.47	0.25	0.29	0.84		0.31	-0.53	0.8	-0.03	-0.32	-0.38	-0.35	-0.3	-0.39	-0.3
Short Term Debt	0.24	-0.01	-0.32	-0.17	-0.1	0.69	0.23	-0.22	0.56	0.29	0.31		0.34	-0.14	0.44	0.67	0.65	0.63	0.69	0.19	0.34
Intangible Assets	-0.62	-0.67	-0.28	0.04	0.44	0.61	0.62	-0.55	0.43	-0.2	-0.53	0.34		-0.84	-0.11	0.8	0.87	0.83	0.55	0.87	0.83
Common Stock	0.87	0.66	-0.05	0.15	-0.73	-0.22	-0.67	0.42	-0.27	0.51	0.8	-0.14	-0.84		-0.12	-0.64	-0.72	-0.66	-0.59	-0.66	-0.54
Net Tangible Assets	-0.06	-0.03	0.58	-0.12	0.09	0.13	0.17	0.31	0.07	-0.06	-0.03	0.44	-0.11	-0.12		0.35	0.31	0.16	0.7	-0.37	-0.39
Long Term Debt	-0.4	-0.5	-0.16	-0.01	0.27	0.84	0.56	-0.33	0.42	-0.09	-0.32	0.67	0.8	-0.64	0.35		0.98	0.94	0.84	0.56	0.69
Net Invested Capital	-0.47	-0.57	-0.18	0.0	0.31	0.77	0.59	-0.46	0.47	-0.11	-0.38	0.65	0.87	-0.72	0.31	0.98		0.96	0.86	0.66	0.72
Capital Stock	-0.43	-0.53	-0.34	0.01	0.27	0.75	0.48	-0.54	0.46	-0.1	-0.35	0.63	0.83	-0.66	0.16	0.94	0.96		0.78	0.71	0.84
Net Working Capital	-0.38	-0.43	0.1	-0.06	0.27	0.53	0.45	-0.33	0.37	-0.11	-0.3	0.69	0.55	-0.59	0.7	0.84	0.86	0.78		0.28	0.32
Property Plant Equipment	-0.46	-0.57	-0.39	0.1	0.29	0.45	0.48	-0.49	0.46	-0.11	-0.39	0.19	0.87	-0.66	-0.37	0.56	0.66	0.71	0.28		0.87
Short Long Term Debt	-0.35	-0.46	-0.61	0.08	0.2	0.65	0.36	-0.58	0.39	-0.06	-0.3	0.34	0.83	-0.54	-0.39	0.69	0.72	0.84	0.32	0.87

Click cells to compare fundamentals

About Journey Medical Financial Statements

Journey Medical investors utilize fundamental indicators, such as Net Debt, to predict how Journey Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.

	Last Reported	Projected for Next Year
Net Debt	-9.7 M	-10.2 M
Net Debt To EBITDA	(5.05)	(4.80)

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect

When determining whether Journey Medical Corp is a strong investment it is important to analyze Journey Medical's competitive position within its industry, examining market share, product or service uniqueness, and competitive advantages. Beyond financials and market position, potential investors should also consider broader economic conditions, industry trends, and any regulatory or geopolitical factors that may impact Journey Medical's future performance. For an informed investment choice regarding Journey Stock, refer to the following important reports:

How To Invest In Journey

Details

Is Journey Stock a good investment?

Details

What is Journey Medical's Net Worth?

Details

Largest Biotechnology Companies

View

Largest Pharmaceuticals, Biotechnology & Life Sciences Companies

View

Check out the analysis of Journey Medical Correlation against competitors.

You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Journey Medical. If investors know Journey will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Journey Medical listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.

Earnings Share

(0.92)

Revenue Per Share

2.921

Quarterly Revenue Growth

(0.58)

Return On Assets

(0.17)

Return On Equity

(1.30)

The market value of Journey Medical Corp is measured differently than its book value, which is the value of Journey that is recorded on the company's balance sheet. Investors also form their own opinion of Journey Medical's value that differs from its market value or its book value, called intrinsic value, which is Journey Medical's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Journey Medical's market value can be influenced by many factors that don't directly affect Journey Medical's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.

Please note, there is a significant difference between Journey Medical's value and its price as these two are different measures arrived at by different means. Investors typically determine if Journey Medical is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Journey Medical's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Macroaxis helps investors of all levels and skills to maximize the upside of all their holdings and minimize the risk associated with market volatility, economic swings, and company-specific events. View terms and conditions

Feedback Blog

Made with optimal in San Francisco

2024 Macroaxis LLC

Journey Net Debt from 2010 to 2024

Latest Journey Medical's Net Debt Growth Pattern

Journey Net Debt Regression Statistics

Journey Net Debt History

Other Fundumenentals of Journey Medical Corp

Journey Medical Net Debt component correlations

About Journey Medical Financial Statements

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

COMMON DESTINATIONS

MAIN CATEGORIES

COMPANY